Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma
Background: Advanced pancreatic adenocarcinoma still remains associated with a desperate prognosis. Nevertheless, treatment options for patients with metastasized disease have improved considerably over the last few years. Recently, cytotoxic combination therapies such as the FOLFIRINOX regimen and...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
November 20, 2013
|
| In: |
Onkologie
Year: 2013, Volume: 36, Issue: 12, Pages: 763-765 |
| ISSN: | 1423-0240 |
| DOI: | 10.1159/000356811 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000356811 Verlag, lizenzpflichtig, Volltext: https://www.karger.com/Article/FullText/356811 |
| Author Notes: | Anne K. Berger, Tim F. Weber, Dirk Jäger, Christoph Springfeld |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1740385705 | ||
| 003 | DE-627 | ||
| 005 | 20230428084927.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201123s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000356811 |2 doi | |
| 035 | |a (DE-627)1740385705 | ||
| 035 | |a (DE-599)KXP1740385705 | ||
| 035 | |a (OCoLC)1341377956 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Berger, Anne Katrin |d 1978- |e VerfasserIn |0 (DE-588)132177889 |0 (DE-627)519022424 |0 (DE-576)298988380 |4 aut | |
| 245 | 1 | 0 | |a Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma |c Anne K. Berger, Tim F. Weber, Dirk Jäger, Christoph Springfeld |
| 264 | 1 | |c November 20, 2013 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.11.2020 | ||
| 520 | |a Background: Advanced pancreatic adenocarcinoma still remains associated with a desperate prognosis. Nevertheless, treatment options for patients with metastasized disease have improved considerably over the last few years. Recently, cytotoxic combination therapies such as the FOLFIRINOX regimen and combined nab-paclitaxel/gemcitabine have shown improved overall survival compared to gemcitabine alone. There is still no standard of care in second-line therapy for patients with disease progression. Case Report: We report the case of a 47-year-old patient who dramatically responded to second-line treatment with nab-paclitaxel and gemcitabine after primary progression to the FOLFIRINOX protocol. Conclusion: Second-line treatment after FOLFIRINOX is feasible for patients with good performance status. Our case report supports preclinical findings that suggest that pancreatic cancer is a heterogeneous disease. Further studies that characterize possible subgroups and identify predictive molecular markers to guide therapy are warranted. | ||
| 700 | 1 | |a Weber, Tim |d 1977- |e VerfasserIn |0 (DE-588)133392694 |0 (DE-627)544045017 |0 (DE-576)299816613 |4 aut | |
| 700 | 1 | |a Jäger, Dirk |d 1964- |e VerfasserIn |0 (DE-588)1032507535 |0 (DE-627)738505323 |0 (DE-576)380074125 |4 aut | |
| 700 | 1 | |a Springfeld, Christoph |d 1972- |e VerfasserIn |0 (DE-588)123388910 |0 (DE-627)706281039 |0 (DE-576)293689385 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Onkologie |d Basel : Karger, 1978 |g 36(2013), 12, Seite 763-765 |h Online-Ressource |w (DE-627)300595417 |w (DE-600)1483097-8 |w (DE-576)105282863 |x 1423-0240 |7 nnas |a Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma |
| 773 | 1 | 8 | |g volume:36 |g year:2013 |g number:12 |g pages:763-765 |g extent:3 |a Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma |
| 856 | 4 | 0 | |u https://doi.org/10.1159/000356811 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.karger.com/Article/FullText/356811 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201123 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 123388910 |a Springfeld, Christoph |m 123388910:Springfeld, Christoph |d 910000 |d 910100 |e 910000PS123388910 |e 910100PS123388910 |k 0/910000/ |k 1/910000/910100/ |p 4 |y j | ||
| 998 | |g 1032507535 |a Jäger, Dirk |m 1032507535:Jäger, Dirk |d 910000 |e 910000PJ1032507535 |k 0/910000/ |p 3 | ||
| 998 | |g 133392694 |a Weber, Tim |m 133392694:Weber, Tim |d 910000 |d 911400 |e 910000PW133392694 |e 911400PW133392694 |k 0/910000/ |k 1/910000/911400/ |p 2 | ||
| 998 | |g 132177889 |a Berger, Anne Katrin |m 132177889:Berger, Anne Katrin |d 910000 |d 910100 |e 910000PB132177889 |e 910100PB132177889 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1740385705 |e 3810440876 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1740385705","name":{"displayForm":["Anne K. Berger, Tim F. Weber, Dirk Jäger, Christoph Springfeld"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"November 20, 2013"}],"id":{"eki":["1740385705"],"doi":["10.1159/000356811"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"3 S."}],"title":[{"title":"Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma","title_sort":"Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma"}],"person":[{"display":"Berger, Anne Katrin","role":"aut","given":"Anne Katrin","family":"Berger"},{"role":"aut","given":"Tim","family":"Weber","display":"Weber, Tim"},{"family":"Jäger","given":"Dirk","role":"aut","display":"Jäger, Dirk"},{"family":"Springfeld","role":"aut","given":"Christoph","display":"Springfeld, Christoph"}],"relHost":[{"title":[{"title_sort":"Onkologie","subtitle":"international journal for cancer research and treatment","title":"Onkologie"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 15.12.2023"],"language":["ger"],"pubHistory":["1.1978 - 36.2013"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["300595417"],"zdb":["1483097-8"],"issn":["1423-0240"]},"origin":[{"publisherPlace":"Basel","publisher":"Karger","dateIssuedKey":"1978","dateIssuedDisp":"1978-2013"}],"part":{"text":"36(2013), 12, Seite 763-765","extent":"3","pages":"763-765","volume":"36","year":"2013","issue":"12"},"recId":"300595417","disp":"Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinomaOnkologie"}],"note":["Gesehen am 23.11.2020"]} | ||
| SRT | |a BERGERANNESUCCESSFUL2020 | ||